5 April 2025 in Journal of Chemical Theory and Computation
Directionality in molecular and biomolecular networks plays an important role in the accurate representation of the complex, dynamic, and asymmetrical nature of interactions present in protein-ligand binding, signal transduction, and biological pathways. Most traditional techniques of topological data analysis (TDA), such as persistent homology (PH) and persistent Laplacian (PL), overlook this aspect in their standard form. To address this, we present the persistent directed flag Laplacian (PDFL), which incorporates directed flag complexes to account for edges with directionality originated from polarization, gene regulation, heterogeneous interactions, etc. This study marks the first application of PDFL, providing an in-depth analysis of spectral graph theory combined with machine learning. In addition to its superior accuracy and reliability, the PDFL model offers simplicity by requiring only raw inputs without complex data processing. We validated our multikernel PDFL model for its scoring power against other state-of-the-art methods on three popular benchmarks, namely PDBbind v2007, v2013, and v2016. The computational results indicate that the proposed PDFL model outperforms competitors in protein-ligand binding affinity predictions, suggesting that PDFL is a promising tool for protein engineering, drug discovery, and general applications in science and engineering.
1 January 2025 in Foundations of Data Science
Topological data analysis (TDA) has had enormous success in science and engineering in the past decade. Persistent topological Laplacians (PTLs) overcome some limitations of persistent homology, a key technique in TDA, and provide substantial insight to the behavior of various geometric and topological objects. This work extends PTLs to directed flag complexes, which are an exciting generalization to flag complexes, also known as clique complexes, that arise naturally in many situations. We introduce the directed flag Laplacian and show that the proposed persistent directed flag Laplacian (PDFL) is a distinct way of analyzing these flag complexes. Example calculations are provided to demonstrate the potential of the proposed PDFL in real world applications.
1 June 2025 in Journal of Physics: Complexity
Khovanov homology has been the subject of much study in knot theory and low dimensional topology since 2000. This work introduces a Khovanov Laplacian and a Khovanov Dirac to study knot and link diagrams. The harmonic spectrum of the Khovanov Laplacian or the Khovanov Dirac retains the topological invariants of Khovanov homology, while their non-harmonic spectra reveal additional information that is distinct from Khovanov homology.
4 November 2025 in Journal of Chemical Information and Modeling
The ongoing opioid crisis highlights the urgent need for novel therapeutic strategies that can be rapidly deployed. This study presents a novel approach to identify potential repurposable drugs for the treatment of opioid addiction, aiming to bridge the gap between transcriptomic data analysis and drug discovery. Specifically, we perform a meta-analysis of seven transcriptomic data sets related to opioid addiction by differential gene expression (DGE) analysis and propose a novel multiscale topological differentiation to identify key genes from a protein-protein interaction (PPI) network derived from DEGs. This method uses persistent Laplacians to accurately single out important nodes within the PPI network through a multiscale manner to ensure high reliability. Subsequent functional validation by pathway enrichment and rigorous data curation yields 1,865 high-confidence targets implicated in opioid addiction, which are cross-referenced with DrugBank to compile a repurposing candidate list. To evaluate drug-target interactions, we construct predictive models utilizing two natural language processing-derived molecular embeddings and a conventional molecular fingerprint. Based on these models, we prioritize compounds with favorable binding affinity profiles, and select candidates that are further assessed through molecular docking simulations to elucidate their receptor-level interactions. Additionally, pharmacokinetic and toxicological evaluations are performed via ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiling, providing a multidimensional assessment of druggability and safety. This study offers a generalizable approach for drug repurposing in other complex diseases beyond opioid addiction.
8 September 2026 in SSRN Electronic Journal
Accurate prediction of protein-ligand binding affinity remains a central challenge in computational drug discovery due to the complex interplay among molecular geometry, physicochemical interactions, and atom-specific charge information. In this work, we introduce a Persistent Sheaf Laplacian learning (PSLL) framework for protein-ligand binding affinity prediction. The proposed approach constructs multiscale topological representations from three-dimensional protein-ligand complexes by incorporating atomic partial charges into sheaf restriction maps over Vietoris-Rips and alpha complex filtrations. To capture chemically diverse protein-ligand interactions, we introduce element-specific and category-specific atom-pair representations within the PSLL framework. Harmonic and non-harmonic spectra extracted from the resulting persistent sheaf Laplacians are used as molecular descriptors. To complement the PSLL-derived molecular representation, we incorporate transformer-based protein embeddings and SMILES-derived ligand descriptors for binding affinity prediction. The scoring power of the proposed multiscale PSLL model is validated against existing state-of-the-art methods on three widely used PDBbind benchmark datasets, including PDBbind-v2007, PDBbind-v2013, and PDBbind-v2016. The computational results indicate that the proposed PSLL model achieves strong predictive performance across benchmark datasets, highlighting its potential as an interpretable and mathematically grounded framework with promising generalizability for molecular machine learning and drug discovery.